Security Snapshot

ORTHOPEDIATRICS CORP - Common Stock, par value $0.00025 per share (KIDS) Institutional Ownership

CUSIP: 68752L100

13F Institutional Holders and Ownership History from Q4 2017 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

62

Shares (Excl. Options)

7.25MFull value: 7,251,784 · shares · 30 Sep 2026

Price

$22.27

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+915,983
Value change
+$20,893,589
Number of holders
62
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
26,134,510
SEC-reported price per share
$22.16
Insider filing price
$22.16
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • KIDS - ORTHOPEDIATRICS CORP - Common Stock, par value $0.00025 per share is tracked under CUSIP 68752L100.
  • 62 institutions reported positions in Q3 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 118 to 62 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $316.54MFull value: $316,540,920 · USD · 30 Jun 2026
    to
    $161.48MFull value: $161,478,266 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 62 institutions filings for Q3 2026.

Open SEC evidence

Security key

68752L100

13F reference period

Q3 2026

13F holders

62

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
KIDS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Squadron Capital LLC 24% -5.2% $142,599,559 -$7,416,759 6,246,148 -4.9% David R. Pelizzon 10 Sep 2026
BlackRock, Inc. 5% $26,436,748 1,230,784 BlackRock, Inc. 30 Jun 2025
BROWN CAPITAL MANAGEMENT LLC 4.3% -35% $20,035,007 -$10,919,822 1,081,220 -35% Brown Capital Management, LLC 30 Sep 2025
INTEGRATED CORE STRATEGIES (US) LLC 3.2% -38% $15,626,040 -$10,977,349 816,830 -41% Millennium Management LLC 30 Jun 2026
As of 30 Sep 2026, 62 institutional investors reported holding
7.25MFull value: 7,251,784 · shares · 30 Sep 2026
shares of ORTHOPEDIATRICS CORP - Common Stock, par value $0.00025 per share (KIDS). This represents 28% of the company’s total
26.13MFull value: 26,134,510 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
27%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
AIGH Capital Management LLC 4.5% 1,171,765 +334% 3% $26,095,207
VANGUARD CAPITAL MANAGEMENT LLC 2.9% 751,680 -0.52% 0% $16,739,914
MORGAN STANLEY 2.3% 602,224 -13% 0% $13,411,557
DIMENSIONAL FUND ADVISORS LP 1.9% 497,455 +3.5% 0% $11,079,676
WASATCH ADVISORS LP 1.8% 469,449 -9% 0.08% $10,454,629
STATE STREET CORP 1.7% 443,198 +13% 0% $9,870,019
GEODE CAPITAL MANAGEMENT, LLC 1.7% 432,835 -4.3% 0% $9,641,949
Roubaix Capital, LLC 1.3% 340,555 +11% 3% $7,584,160
RIVERBRIDGE PARTNERS LLC 1.2% 324,447 +109% 0.21% $7,225,435
Nantahala Capital Management, LLC 0.93% 242,342 0% 0.3% $5,396,956
AWM Investment Company, Inc. 0.91% 237,169 0% 0.51% $5,281,754
Triodos Investment Management BV 0.72% 187,500 +14% 0.26% $4,175,625
KENNEDY CAPITAL MANAGEMENT LLC 0.68% 177,460 -3% 0.07% $3,952,034
VANGUARD PORTFOLIO MANAGEMENT LLC 0.67% 174,178 +1.7% 0% $3,878,944
HARBOR CAPITAL ADVISORS, INC. 0.66% 171,482 -14% 0.26% $3,819,000
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 0.55% 143,486 -1.4% 0.03% $3,195,433
VANGUARD FIDUCIARY TRUST CO 0.45% 118,768 +1.3% 0% $2,644,963
BROWN CAPITAL MANAGEMENT LLC 0.34% 89,203 -42% 0.38% $1,986,551
Conestoga Capital Advisors, LLC 0.29% 74,975 +16% 0.05% $1,669,693
COMMONWEALTH EQUITY SERVICES, LLC 0.24% 61,762 -14% 0% $1,375,440
Prime Capital Investment Advisors, LLC 0.2% 52,047 -17% 0.01% $1,159,087
PARADIGM CAPITAL MANAGEMENT INC/NY 0.18% 47,000 0% 0.03% $1,046,690
AMERICAN CENTURY COMPANIES INC 0.16% 41,846 +3.3% 0% $931,910
Ellsworth Advisors, LLC 0.15% 40,422 0.15% $900,198
SG Capital Management LLC 0.14% 37,809 0.07% $842,006

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
36
Headline period
Q3 2026
Rows shown
1-25 of 36
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 7,251,784 $161,478,266 +$20,893,589 $22.27 62
2026 Q2 16,549,843 $316,540,920 +$5,108,598 $19.13 118
2026 Q1 16,310,889 $258,874,432 -$1,095,886 $15.87 120
2025 Q4 16,313,355 $289,753,004 -$4,111,125 $17.76 120
2025 Q3 16,501,828 $305,775,919 -$6,455,185 $18.53 110
2025 Q2 16,817,981 $361,248,552 +$2,212,295 $21.48 116
2025 Q1 16,691,588 $411,125,012 +$5,143,009 $24.63 114
2024 Q4 16,501,406 $382,504,159 +$773,471 $23.18 107
2024 Q3 16,333,743 $442,837,473 +$1,584,968 $27.11 121
2024 Q2 16,242,247 $467,138,707 +$10,095,978 $28.76 120
2024 Q1 15,892,946 $463,440,165 -$12,906,846 $29.16 117
2023 Q4 16,261,994 $528,667,001 -$251,450 $32.51 126
2023 Q3 16,271,554 $521,018,497 +$6,205,213 $32.00 115
2023 Q2 15,984,589 $701,031,443 -$10,062,157 $43.85 120
2023 Q1 16,213,938 $717,721,563 +$13,280,226 $44.29 120
2022 Q4 15,969,552 $634,638,489 -$20,370,351 $39.73 117
2022 Q3 15,319,596 $706,913,920 +$7,022,250 $46.14 120
2022 Q2 15,147,316 $653,533,661 +$9,822,525 $43.15 112
2022 Q1 14,882,764 $803,548,443 +$23,227,965 $53.99 121
2021 Q4 14,446,519 $864,710,320 -$43,598,809 $59.86 123
2021 Q3 14,787,776 $968,927,802 -$16,120,535 $65.51 140
2021 Q2 15,040,814 $950,122,354 +$34,742,154 $63.18 136
2021 Q1 14,650,983 $714,225,765 -$10,678,703 $48.75 122
2020 Q4 15,132,644 $624,376,779 +$44,734,958 $41.25 130
2020 Q3 13,957,347 $640,952,762 +$41,183,608 $45.92 122
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .